Skip to main content
PLEASE NOTE: For everyone’s safety, Fasken requires anyone on-site at our Canadian and Johannesburg offices to provide proof of full vaccination against COVID-19. This applies to lawyers, staff, clients, service providers and other visitors.
Guide

A Novel Doxorubicin-Mitomycin C Co-Encapsulated Nanoparticle Formulation Exhibits Anti-Cancer Synergy in Multidrug Resistant Human Breast Cancer Cells

Fasken
Reading Time 1 minute read

Overview

Breast Cancer Res. Treatment 2010; 119(2): 255-269

Richard Cheung co-wrote the piece titled, A Novel Doxorubicin-Mitomycin C Co-Encapsulated Nanoparticle Formulation Exhibits Anti-Cancer Synergy in Multidrug Resistant Human Breast Cancer Cells.